About Koneksa
Koneksa Announces Positive Topline Results from KH007 Study Evaluating Digital Measures of Parkinson’s Disease Progression
Study meets primary compliance endpoint, reinforcing the value of Koneksa’s integrated measurement platform and syndicated, precompetitive study model with partners Merck and Regeneron. Punta Gorda, FL — September 1, 2026 —Koneksa Health…
Koneksa Launches the First Intelligent Submission Software to Unify the Clinical Submission Pipeline in a Single Auditable Workflow
Purpose-built for biometrics and regulatory operations, Lodestar™ eliminates submission pipeline fragmentation through AI-assisted, auditable workflow, validated in completed LEARNS clinical study. New York, NY — June 2, 2026 —…
Koneksa Achieves Key Milestone with Database Lock for KH007 Study Evaluating Parkinson’s Disease Progression
Completion of data collection enables full analysis, with topline results expected in June 2026 New York, NY — 23 April 2026 — Koneksa, a measurement-science partner for clinical development,…
Upcoming Events
No event found!
